Data / Drug companies / Amorepacific Corporation
Amorepacific Corporation: 93 products in the FDA NDC directory, labeler code 43419
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Amorepacific Corporation (labeler code 43419) lists 93 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 93 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 1, 2026.
The request: Watch Amorepacific Corporation (FDA labeler code 43419): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 43419
- Products in commercial distribution
- 93
- Packages
- 93
- Finished drugs by generic name
- 9
- Prescription products
- 0
- Over the counter products
- 93
- Flagged as original packager
- 23 of 23 products that carry the flag
- Started marketing in the last 12 months
- 79
- Products with a marketing end date set
- 4
- Earliest marketing start
- December 5, 2012
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 93 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 93 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Titanium dioxide | 40 | 51 |
| Octinoxate, titanium dioxide, and zinc oxide | 20 | 4 |
| Octinoxate | 19 | 10 |
| Octinoxate, titanium dioxide, and homosalate | 7 | 1 |
| Zinc oxide, octinoxate, and titanium dioxide | 3 | 1 |
| Homosalate, octinoxate,octisalate, and titanium dioxide | 1 | 1 |
| Avobenzone, homosalate, octisalate, octocrylene cream | 1 | 1 |
| Octocrylene, homosalate, octisalate, avobenzone | 1 | 17 |
| Homosalate, octocrylene, octisalate, avobenzone | 1 | 26 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Lotion | 90 | 96.8% |
| Cream | 3 | 3.2% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Hera black cushion foundation 50n1 | 43419-278 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 48n1 | 43419-277 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 47n1 | 43419-276 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 45w1 | 43419-275 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 43o1 | 43419-274 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 43n1 | 43419-273 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 41w1 | 43419-272 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 39n1 | 43419-271 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 37w1 | 43419-270 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 35n1 | 43419-269 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 35c1 | 43419-268 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 32w1 | 43419-267 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 31n1 | 43419-266 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 31c1 | 43419-265 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 29w1 | 43419-264 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 29n1 | 43419-263 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 28o1 | 43419-262 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 28n1 | 43419-261 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 28c1 | 43419-260 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 26w1 | 43419-251 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 26n1 | 43419-250 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 22n1 | 43419-249 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 22n1 | 43419-248 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 22n1 | 43419-247 | Lotion | Over the counter monograph drugs | September 1, 2026 |
| Hera black cushion foundation 21w1 | 43419-246 | Lotion | Over the counter monograph drugs | September 1, 2026 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.